|
Video: What is a Stock Split?
|
|
Haemonetics is a global healthcare company providing a suite of medical products and solutions for customers. Co.'s technology addresses medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. Co. has three principal reporting segments: Plasma, which provides automated plasma collection and donor management software systems; Blood Center, which provides a range of solutions that improve donor collection centers' ability to collect and filter blood and separate blood components; and Hospital, which has four product lines, including Hemostasis Management, Vascular Closure, Transfusion Management and Cell Salvage. According to our Haemonetics stock split history records, Haemonetics has had 2 splits. | |
|
Haemonetics (HAE) has 2 splits in our Haemonetics stock split history database. The first split for HAE took place on January 11, 1993. This was a 2 for 1
split, meaning for each share of HAE owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split. HAE's second split took place on December 03, 2012. This was a 2 for 1 split, meaning for each share of HAE owned pre-split, the shareholder now owned 2 shares. For example, a 2000 share position pre-split, became a 4000 share position following the split.
When a company such as Haemonetics splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the Haemonetics stock split history from start to finish, an original position size of 1000 shares would have turned into 4000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Haemonetics shares, starting with a $10,000 purchase of HAE, presented on a split-history-adjusted basis factoring in the complete Haemonetics stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/22/2014 |
|
End date: |
04/17/2024 |
|
Start price/share: |
$33.82 |
|
End price/share: |
$84.88 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
150.98% |
|
Average Annual Total Return: |
9.64% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$25,088.30 |
|
Years: |
9.99 |
|
|
|
Date |
Ratio |
01/11/1993 | 2 for 1
| 12/03/2012 | 2 for 1 |
|
|